Survival and Disease Recurrence in Patients with Duodenal Neuroendocrine Tumours-A Single Centre Cohort

被引:10
作者
Folkestad, Oddry [1 ,2 ]
Wasmuth, Hans H. [3 ]
Mjones, Patricia [3 ,4 ]
Fougner, Reidun [5 ]
Hauso, Oyvind [3 ,6 ]
Fossmark, Reidar [3 ,6 ]
机构
[1] Trondheim Reg & Univ Hosp, Dept Gastrointestinal Surg, St Olavs Hosp, N-7030 Trondheim, Norway
[2] Vestfold Hosp, Dept Gastrointestinal Surg, N-3103 Tonsberg, Norway
[3] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Clin & Mol Med, N-7030 Trondheim, Norway
[4] Trondheim Reg & Univ Hosp, Dept Pathol, St Olavs Hosp, N-7030 Trondheim, Norway
[5] Trondheim Reg & Univ Hosp, Dept Radiol, St Olavs Hosp, N-7030 Trondheim, Norway
[6] Trondheim Reg & Univ Hosp, Dept Gastroenterol & Hepatol, St Olavs Hosp, N-7030 Trondheim, Norway
关键词
neuroendocrine tumour; duodenum; endoscopy; surgery; survival; recurrence; outcome; CONSENSUS GUIDELINES UPDATE; CARCINOID-TUMORS; TNM CLASSIFICATION; NEOPLASMS; RESECTION; AMPULLA; SYSTEM; VATER;
D O I
10.3390/cancers13163985
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Neuroendocrine tumours of the upper part of the small intestine are rare. They are slow growing but may spread to lymph nodes or other organs already when the tumours are small. Such tumours may be treated by endoscopic removal or by an operation. In the current study we present the treatment results of 32 patients with this rare tumour. We found that the long-term survival was long, and patients more often died from other diseases. The survival was associated with the growth rate of the tumours and whether all the tumour tissue could be removed. Endoscopic removal was sufficient for smaller tumours <10 mm, whereas a high proportion of tumours 10-20 mm have lymph node metastases that must be removed by an operation to make patients tumour free. None of the tumours that were perceived as cured after removal recurred after an average follow-up time of 4.8 years. Background: Duodenal neuroendocrine tumours (D-NETs) are rare but increasingly diagnosed. This study aimed to assess the overall survival and recurrence rate among patients treated for D-NETs. Methods: Patients with D-NETs were retrospectively reviewed with a median follow-up time of 4.8 years (range 0.0-17.2 years). Results: A total of 32 patients with median age 68.0 years were identified. Fifteen patients underwent surgery while ten patients underwent endoscopic treatment. Mean estimated overall survival for the entire population was 12.1 years (95% CI 9.5-14.7 years), while 5-year overall survival was 81.3%. Tumour grade G1 was associated with longer mean estimated survival compared to G2 tumours (13.2 years versus 4.4 years, p = 0.010). None of the 23 patients who underwent presumed radical endoscopic or surgical resection had disease recurrence during follow-up. Tumours <10 mm could be treated endoscopically whereas a high proportion of patients with tumours 10-20 mm should be considered for surgery. Conclusion: Patients with D-NETs had long overall survival, and mortality was more influenced by other diseases. Both endoscopic and surgical resections were effective as no recurrences were diagnosed during follow-up.
引用
收藏
页数:10
相关论文
共 35 条
  • [1] Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study
    Amini, Neda
    Kim, Yuhree
    Wilson, Ana
    Margonis, Georgios Antonios
    Ethun, Cecilia G.
    Poultsides, George
    Thuy Tran
    Idrees, Kamran
    Isom, Chelsea A.
    Fields, Ryan C.
    Krasnick, Bradley
    Weber, Sharon M.
    Salem, Ahmed
    Martin, Robert C. G.
    Scoggins, Charles
    Shen, Perry
    Mogal, Harveshp D.
    Schmidt, Carl
    Beal, Eliza
    Hatzaras, Ioannis
    Shenoy, Rivfka
    Maithel, Shishir K.
    Pawlik, Timothy M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (09) : 3016 - 3023
  • [2] Carcinoid tumors of the duodenum and ampulla of Vater:: A clinicomorphologic, immunohistochemical, and cell kinetic comparison
    Bornstein-Quevedo, L
    Gamboa-Domínguez, A
    [J]. HUMAN PATHOLOGY, 2001, 32 (11) : 1252 - 1256
  • [3] BURKE AP, 1990, ARCH PATHOL LAB MED, V114, P700
  • [4] Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature
    Dasari, Bobby V. M.
    Al-Shakhshir, Sarah
    Pawlik, Timothy M.
    Shah, Tahir
    Marudanayagam, Ravi
    Sutcliffe, Robert P.
    Mirza, Darius F.
    Muiesan, Paolo
    Roberts, Keith J.
    Isaac, John
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (09) : 1652 - 1658
  • [5] ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
    Delle Fave, G.
    O'Toole, D.
    Sundin, A.
    Taal, B.
    Ferolla, P.
    Ramage, J. K.
    Ferone, D.
    Ito, T.
    Weber, W.
    Zheng-Pei, Z.
    De Herder, W. W.
    Pascher, A.
    Ruszniewski, P.
    [J]. NEUROENDOCRINOLOGY, 2016, 103 (02) : 119 - 124
  • [6] Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours
    Exarchou, Klaire
    Howes, Nathan
    Pritchard, David Mark
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (12) : 1247 - 1267
  • [7] Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease?
    Fitzgerald, Timothy L.
    Dennis, Samuel O.
    Kachare, Swapnil D.
    Vohra, Nasreen A.
    Zervos, Emmanuel E.
    [J]. SURGERY, 2015, 158 (02) : 466 - 471
  • [8] Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?
    Gamboa, Adriana C.
    Liu, Yuan
    Lee, Rachel M.
    Zaidi, Mohammad Y.
    Staley, Charles A.
    Kooby, David A.
    Winer, Joshua H.
    Shah, Mihir M.
    Russell, Maria C.
    Cardona, Kenneth
    Maithel, Shishir K.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (08) : 1293 - 1301
  • [9] The Risk Factors for Metastasis in Non-Ampullary Duodenal Neuroendocrine Tumors Measuring 20 mm or Less in Diameter
    Hatta, Waku
    Koike, Tomoyuki
    Iijima, Katsunori
    Asanuma, Kiyotaka
    Asano, Naoki
    Musha, Hiroaki
    Inomata, Yoshifumi
    Sano, Toshikazu
    Endo, Hiroyuki
    Ikehata, Atsushi
    Horii, Toru
    Ohyauchi, Motoki
    Yokosawa, Satoshi
    Kasajima, Atsuko
    Fujishima, Fumiyoshi
    Sasano, Hironobu
    Nakaya, Naoki
    Nakamura, Tomohiro
    Shimosegawa, Tooru
    [J]. DIGESTION, 2017, 95 (03) : 201 - 209
  • [10] HATZITHEOKLITOS E, 1994, CANCER-AM CANCER SOC, V73, P1580, DOI 10.1002/1097-0142(19940315)73:6<1580::AID-CNCR2820730608>3.0.CO